DK1654284T3 - Fremgangsmåde til fremstilling af en alfa-1-antitrypsinoplösning - Google Patents

Fremgangsmåde til fremstilling af en alfa-1-antitrypsinoplösning

Info

Publication number
DK1654284T3
DK1654284T3 DK04764046T DK04764046T DK1654284T3 DK 1654284 T3 DK1654284 T3 DK 1654284T3 DK 04764046 T DK04764046 T DK 04764046T DK 04764046 T DK04764046 T DK 04764046T DK 1654284 T3 DK1654284 T3 DK 1654284T3
Authority
DK
Denmark
Prior art keywords
a1at
preparing
alpha
detergents
antitrypsin solution
Prior art date
Application number
DK04764046T
Other languages
English (en)
Inventor
Petra Schulz
Juergen Roemisch
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of DK1654284T3 publication Critical patent/DK1654284T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
DK04764046T 2003-08-12 2004-08-12 Fremgangsmåde til fremstilling af en alfa-1-antitrypsinoplösning DK1654284T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49409703P 2003-08-12 2003-08-12
PCT/EP2004/009043 WO2005014648A1 (en) 2003-08-12 2004-08-12 Process for preparing an alpha-1-antitrypsin solution

Publications (1)

Publication Number Publication Date
DK1654284T3 true DK1654284T3 (da) 2009-07-20

Family

ID=34135316

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04764046T DK1654284T3 (da) 2003-08-12 2004-08-12 Fremgangsmåde til fremstilling af en alfa-1-antitrypsinoplösning

Country Status (22)

Country Link
US (1) US20060194300A1 (da)
EP (1) EP1654284B1 (da)
JP (1) JP4668904B2 (da)
KR (1) KR20060070543A (da)
CN (1) CN1867582B (da)
AT (1) ATE428730T1 (da)
AU (1) AU2004262578B2 (da)
BR (1) BRPI0412835A (da)
CA (1) CA2534900A1 (da)
DE (1) DE602004020632D1 (da)
DK (1) DK1654284T3 (da)
ES (1) ES2324168T3 (da)
IL (1) IL172868A0 (da)
NO (1) NO20060109L (da)
PL (1) PL1654284T3 (da)
PT (1) PT1654284E (da)
RS (1) RS20060077A (da)
RU (1) RU2370500C2 (da)
SI (1) SI1654284T1 (da)
UA (1) UA86775C2 (da)
WO (1) WO2005014648A1 (da)
ZA (1) ZA200601206B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE391730T1 (de) * 2003-09-22 2008-04-15 Kamada Ltd Herstellung eines alpha-1-proteinaseinhibitors im grossmassstab und dessen verwendung
ES2246694B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Nanoparticulas pegiladas.
ES2246695B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
CN100562523C (zh) * 2006-07-26 2009-11-25 河北大安制药有限公司 α1-抗胰蛋白酶的制备方法
NZ584766A (en) * 2007-11-02 2012-12-21 Grifols Therapeutics Inc Method, composition, and article of manufacture for providing alpha-1 antitrypsin
CN102127165B (zh) * 2010-01-15 2013-09-04 上海莱士血液制品股份有限公司 一种从血浆组分四沉淀中制备高纯ApoA-I的生产工艺
CN102731642B (zh) * 2011-04-14 2014-01-29 上海莱士血液制品股份有限公司 从人血浆组分四沉淀制备高纯Apoa-I的生产工艺
US9353165B2 (en) * 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
AU2013205138B2 (en) * 2012-08-09 2015-06-25 Grifols, S.A. Caprylate Viral Deactivation
MX381279B (es) 2015-06-26 2025-03-12 Ferring Bv Métodos de purificación y/o inactivación viral.
JP6946313B2 (ja) * 2016-02-03 2021-10-06 プラズマ テクノロジーズ エルエルシーＰｌａｓｍａ Ｔｅｃｈｎｏｌｏｇｉｅｓ， Ｌｌｃ 血液系物質からタンパク質を抽出する方法
JP7432506B2 (ja) 2017-10-30 2024-02-16 武田薬品工業株式会社 脂質エンベロープウイルスを不活化するための環境適合性の界面活性剤
CN111991571B (zh) * 2020-08-12 2022-04-05 湖州师范学院 一种柱上低pH病毒灭活的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS584728A (ja) * 1981-05-01 1983-01-11 メデイカル・リサ−チ・インステイチユ−ト・オブ・サンフランシスコ・コ−ポレ−シヨン α−１−抗トリプシンの精製
US4379087A (en) * 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
DE3877041T2 (de) * 1987-04-27 1993-04-22 Miles Inc Verfahren zur herstellung von hochgereinigtem alpha-1-proteinase-inhibitor.
KR920005689B1 (ko) * 1989-12-21 1992-07-13 국제약품공업주식회사 혈청으로부터 알파-1-안티트립신의 분리 정제 및 혈중 알파-1-안티트립신 양의 검정키트
DE4125625C2 (de) * 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
SE9301582D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins
DE4407837C1 (de) * 1994-03-09 1995-08-17 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
EP0871671A1 (en) * 1995-09-07 1998-10-21 PPL Therapeutics (Scotland) Limited Purification of alpha-1 proteinase inhibitor
JP4105249B2 (ja) * 1996-08-09 2008-06-25 財団法人化学及血清療法研究所 α２プラスミンインヒビターの製造方法
AT407114B (de) * 1997-06-10 2000-12-27 Immuno Ag Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
RU2370500C2 (ru) 2009-10-20
EP1654284A1 (en) 2006-05-10
RS20060077A (sr) 2008-08-07
PL1654284T3 (pl) 2009-09-30
NO20060109L (no) 2006-02-15
UA86775C2 (ru) 2009-05-25
IL172868A0 (en) 2006-06-11
CA2534900A1 (en) 2005-02-17
SI1654284T1 (sl) 2009-10-31
ZA200601206B (en) 2007-05-30
WO2005014648A1 (en) 2005-02-17
EP1654284B1 (en) 2009-04-15
JP4668904B2 (ja) 2011-04-13
ES2324168T3 (es) 2009-07-31
US20060194300A1 (en) 2006-08-31
AU2004262578B2 (en) 2010-05-06
RU2006107533A (ru) 2006-07-27
CN1867582B (zh) 2010-06-16
ATE428730T1 (de) 2009-05-15
BRPI0412835A (pt) 2006-09-26
KR20060070543A (ko) 2006-06-23
AU2004262578A1 (en) 2005-02-17
DE602004020632D1 (de) 2009-05-28
JP2007523883A (ja) 2007-08-23
PT1654284E (pt) 2009-07-06
CN1867582A (zh) 2006-11-22

Similar Documents

Publication Publication Date Title
PL1654284T3 (pl) Sposób uzyskiwania roztworu alfa-1-antytrypsyny
MEP10408A (en) Platinum derivative pharmaceutical formulations
DK1301201T3 (da) Behandling af glycogenosis type II
BRPI0412321A (pt) limpeza de membranas de filtração com peróxidos
WO2004037784A3 (en) Pyrrolidones with anti-hiv activity
NZ593214A (en) Compounds and Processes for preparing serine protease inhibitors
EA200201012A1 (ru) Способы стерилизации биологических материалов
AU2003211990A1 (en) Antibody-containing solution pharmaceuticals
DE50309979D1 (de) Neue purinderivate, deren herstelllung und deren verwendung als arzneimittel
ATE373005T1 (de) Thienopyrrole als antivirale mittel
CR8107A (es) Fungicida
DE60111362D1 (de) Stabilisierte ascorbinsäure-lösungen
PE103799A1 (es) Procedimiento de purificacion de mesilato de alatrofloxacino
ATE368645T1 (de) Aminosäurederivate als hiv-protease-inhibitoren
SE0300850D0 (sv) Chemical compounds
IL151669A0 (en) Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
DK1664123T4 (da) Storskalafremstilling af alfa-1-proteinaseinhibitor og anvendelse deraf
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
WO2004037853A3 (en) Quinolones with anti-hiv activity
DE69902816D1 (de) Synthese von heteropolysäuren
DE50306947D1 (de) Sequenzgestell
CO5021214A1 (es) Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene
SE9904289D0 (sv) Method and camposition for the treatment of adenovairal ocular infections
WO2004002430A3 (en) Combinations for the treatment of fungal infections
AU2003302275A1 (en) Bicyclic carbohydrate compounds useful in the treatment of infections caused by flaviviridae sp., such as hepatitis c and bovine viral diarrhea viruses